Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism

The paper evaluates the impact of hormone replacement therapy (HRT) with androgens on cardiac metabolic indicators in men with high cardiovascular risk (CVR) and androgen deficiency state. An open-label randomized clinical trial enrolled 52 men aged 30–64 years with high CVR and detected androgen-de...

Full description

Bibliographic Details
Main Authors: M. N. Mamedov, G. G. Sharvadze, A. A. Yevdokimova
Format: Article
Language:Russian
Published: ABV-press 2014-12-01
Series:Andrologiâ i Genitalʹnaâ Hirurgiâ
Subjects:
Online Access:https://agx.abvpress.ru/jour/article/view/84